Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 4 Incidence of Adverse Events /AE) in individual studies– by system organ class (MedDRA)

From: Black cohosh (Cimicifuga racemosa) is a non-estrogenic alternative to hormone replacement therapy

System organ class

Reported incidence by treatment groups

(KLI-DF-1 2001)

(BI 563.2)

Klimadynon 40 mg

CR BNO 1055 150 mg

CR BNO 1055 300 mg

CE 0.625 mg

Placebo

Menofem /Klimadynon 40 mg

Placebo

N = 30

N = 33

N = 31

N = 34

N = 33

N = 152

N = 159

 

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Patients with AE

12 (40.0)

12 (36.4)

13 (41.9)

13 (38.2)

12 (36.4)

16 (10.5)

17 (10.7)

Blood and lymphatic disorders

      

1 (0.6)

Cardiac disorders

       

Ear and labyrinth disorders

1 (3.3)

   

1 (3.0)

  

Eye disorders

 

1 (3.0)

     

Gastrointestinal disorders

 

2 (6.1)

 

4 (11.8)

 

2 (1.3)

2 (1.3)

General disorders and administration site conditions

     

1 (0.7)

1 (0.6)

Immune system disorders

      

2 (1.3)

Infections and infestations

2 (6.7)

3 (9.1)

1 (3.2)

6 (17.6)

 

5 (3.3)

4 (2.5)

Injury poisoning and procedural complications

2 (6.7)

    

1 (0.7)

 

Investigations

 

4 (12.1)

3 (9.7)

1 (2.9)

 

1 (0.7)

2 (1.3)

Metabolism and nutrition disorders

1 (3.3)

2 (6.1)

  

1 (3.0)

4 (2.6)

5 (3.1)

Musculoskeletal and connective tissue disorders

 

1 (3.0)

1 (3.2)

 

2 (6.1)

1 (0.7)

2 (1.3)

Nervous system disorders

1 (3.3)

1 (3.0)

   

1 (0.7)

1 (0.6)

Psychiatric disorders

 

1 (3.0)

     

Renal and urinary disorders

       

Reproductive system and breast disorders

9 (30.0)

11 (33.3)

12 (38.7)

12 (35.3)

13 (39.4)

1 (0.7)

1 (0.6)

Respiratory, thoracic and mediastinal disorders

1 (3.3)

   

1 (3.0)

  

Skin and subcutaneous disorders

   

1 (2.9)

1 (3.0)

  

Surgical and medical procedures

     

1 (0.7)

 

Vascular disorders

1 (3.3)

     

1 (0.6)